CUMAb

CUMAb: A tool for Computational hUMan AntiBody design

Input

CUMAb Terms

Upload pdb

Mode

Number of designs

Email address

Valid academic email address to send the reports to.

I undertake to use CUMAb on behalf of my non-profit academic institute only. I, on behalf of my institute, accept the Terms and Conditions, whereby, without limitation, the results produced through such use, and any IP rights filed in respect of such results, shall be owned by the technology transfer office of the Weizmann Institute, and may be used by my institute for academic non-commercial purposes only. My institute may not commercialize such results, nor license or transfer such results to any third party for commercial purposes. Click on the question mark to read the Terms & Conditions.*

CUMAb examples

How to interpret CUMAb results

FAQs

CUMAb is free for academic users

Commercial users, please email info.yeda@weizmann.ac.il and fill our contact form

Questions and support
Overview & questions: contact us

Algorithm development
Ariel Tennenhouse & Sarel Fleishman
We thank Rotem Barzilay and Shi Hoch for developing the online interface.

Please cite:

Tennenhouse, A., Khmelnitsky, L., Khalaila, R. et al. Computational optimization of antibody humanness and stability by systematic energy-based ranking. Nat. Biomed. Eng (2023). https://doi.org/10.1038/s41551-023-01079-1